CHI’s IO Summit provides access to a comprehensive 3-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies, appraise computational tools artificial intelligence (AI) and machine learning (ML) for the discovery of new targets, target classes, and combinations to overcome resistance. (Source: Immuno-Oncology Summit )